{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:45:50Z","timestamp":1790095550263,"version":"4.0.1"},"reference-count":52,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.1080\/13543784.2026.2634990","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T07:04:26Z","timestamp":1771830266000},"page":"203-210","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Samelisant (SUVN-G3031), a histamine H3 receptor inverse agonist, as a potential treatment for narcolepsy: a phase-2 drug evaluation"],"prefix":"10.1080","volume":"35","author":[{"given":"Ramakrishna","family":"Nirogi","sequence":"first","affiliation":[{"name":"Suven Life Sciences Limited","place":["Hyderabad, Telangana, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Shinde","sequence":"additional","affiliation":[{"name":"Suven Life Sciences Limited","place":["Hyderabad, Telangana, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramkumar","family":"Subramanian","sequence":"additional","affiliation":[{"name":"Suven Life Sciences Limited","place":["Hyderabad, Telangana, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veera Raghava Chowdary","family":"Palacharla","sequence":"additional","affiliation":[{"name":"Suven Life Sciences Limited","place":["Hyderabad, Telangana, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Benade","sequence":"additional","affiliation":[{"name":"Suven Life Sciences Limited","place":["Hyderabad, Telangana, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renny","family":"Abraham","sequence":"additional","affiliation":[{"name":"Suven Life Sciences Limited","place":["Hyderabad, Telangana, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod Kumar","family":"Goyal","sequence":"additional","affiliation":[{"name":"Suven Life Sciences Limited","place":["Hyderabad, Telangana, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Jayarajan","sequence":"additional","affiliation":[{"name":"Suven Life Sciences Limited","place":["Hyderabad, Telangana, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1500587"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0226-9"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0970"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2024.101993"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00902-9"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab012"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000492"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01051-4"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2024.2354293"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-024-01141-9"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2010.06.004"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1034"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsy183"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.01.014"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.170134"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1124\/mi.6.2.5"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2009.02.011"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01280"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105425"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-05779-x"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120986418"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-020-00920-8"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2024.10.037"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000358740"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.236"},{"key":"e_1_3_4_28_1","unstructured":"Highlights of prescribing information. [cited 2025 Nov 17]. Available from: https:\/\/wakixhcp.com\/pdf\/wakix-tablets-pi.pdf"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2007.05.002"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/35048583"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(24)29209-0"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyy071"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.92.15_supplement.P3.6-035"},{"key":"e_1_3_4_34_1","unstructured":"Current contraceptive status among women aged 15\u201349: United States 2015\u20132017. [cited 2025 Nov 17]. Available from: https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db327.htm"},{"key":"e_1_3_4_35_1","unstructured":"Cooper DB Patel P. Oral contraceptive pills. [Updated 2024 feb 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430882\/"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7966"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2014.10.002"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419875622"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6494"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijchp.2025.100591"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/medsci6010016"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2022.101669"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsaa056.740"},{"key":"e_1_3_4_44_1","unstructured":"Takeda announces positive results from two pivotal phase 3 studies of oveporexton (TAK-861) in narcolepsy type 1. [cited 2025 Nov 17]. Available from: https:\/\/www.takeda.com\/newsroom\/newsreleases\/2025\/positive-results-phase-3-oveporexton-narcolepsy-type-1\/"},{"key":"e_1_3_4_45_1","unstructured":"Alkermes presents detailed positive results from vibrance-1 phase 2 study of alixorexton in patients with narcolepsy type 1 at world sleep congress 2025. [cited 2025 Nov 17]. Available from: https:\/\/investor.alkermes.com\/news-releases\/news-release-details\/alkermes-presents-detailed-positive-results-vibrance-1-phase-2"},{"key":"e_1_3_4_46_1","unstructured":"Alkermes announces positive topline results from vibrance-2 phase 2 study of once-daily alixorexton in patients with narcolepsy type 2. [cited 2025 Nov 17]. Available from: https:\/\/investor.alkermes.com\/news-releases\/news-release-details\/alkermes-announces-positive-topline-results-vibrance-2-phase-2"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsaf090.0838"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.181330998"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.6318"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2010.00053"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0580-17.2017"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/32.9.1127"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2004.03243.x"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2604-09.2009"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2026.2634990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:49:54Z","timestamp":1773402594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2026.2634990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,4]]}},"alternative-id":["10.1080\/13543784.2026.2634990"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2026.2634990","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}